Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Immix Biopharma, Inc. - Common Stock
(NQ:
IMMX
)
1.970
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Immix Biopharma, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Immix Biopharma Announces 16th Patient Dosing in Ongoing Phase 1b/2a IMX-110 Monotherapy Clinical Trial
December 20, 2022
From
Immix Biopharma, Inc.
Via
GlobeNewswire
ImmixBio Ships Tislelizumab for Patient Dosing in its Combination Clinical Trial with IMX-110 in Advanced Solid Tumors
December 19, 2022
From
Immix Biopharma, Inc.
Via
GlobeNewswire
Dow Drops Over 300 Points After Fed Raises Key Overnight Interest Rate By 50 bps
December 14, 2022
U.S. stocks turned lower toward the end of trading, after the Federal Reserve announced its policy decision.
Via
Benzinga
Why Netcapital Shares Are Trading Lower By Over 33%? Here Are 50 Stocks Moving In Wednesday's Mid-Day Session
December 14, 2022
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares rose 153% to $0.3325 after gaining 14% on Tuesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.
Via
Benzinga
Dow Surges Over 100 Points; Charter Communications Shares Slide
December 14, 2022
U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 100 points on Wednesday
Via
Benzinga
Why Immix Biopharma Shares Are Surging Today?
December 14, 2022
Immix Biopharma Inc (NASDAQ: IMMX) announced it has in-licensed BCMA-targeted next-generation CAR-T therapy NXC-201 (formerly HBI0101).
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 14, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 14, 2022
Via
Benzinga
Immix Biopharma in-licenses NXC-201, BCMA-targeted Next-Generation CAR-T Therapy Demonstrating High Complete Response Rate in Heavily Pre-Treated Multiple Myeloma (71% Complete Responses) and AL Amyloidosis (100% Complete Responses)
December 14, 2022
From
Immix Biopharma, Inc.
Via
GlobeNewswire
Immix Biopharma Announces Patient Dosing in Ongoing Phase 1b/2a IMX-110 Monotherapy Clinical Trial
December 13, 2022
From
Immix Biopharma, Inc.
Via
GlobeNewswire
ImmixBio Releases and Ships Scaled-Up GMP Batches of IMX-110 for Clinical Trial Patient Dosing
December 12, 2022
From
Immix Biopharma, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 02, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
October 27, 2022
On Thursday, 111 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
October 26, 2022
On Wednesday, 53 companies reached new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 16, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
August 15, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
October 25, 2022
On Tuesday, 120 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
October 18, 2022
During Tuesday's session, 78 companies made new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
July 19, 2022
Via
Benzinga
121 Stocks That Hit Their 52-Week Low
October 14, 2022
New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 121 stocks hit new 52-week lows.
Via
Benzinga
38 Stocks Moving In Tuesday's Mid-Day Session
June 07, 2022
Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) gained 70% to $0.4900 after the company entered a sponsored research agreement under which in vivo preclinical data will be generated from Kiromic's Gamma...
Via
Benzinga
Dow Brushes Off Rate Hike Fears, Microsoft Warning
June 02, 2022
Investors are attempting to brush off comments from Federal Reserve Vice President Lael Brainard, which reignited rate hike concerns.
Via
Talk Markets
12 Health Care Stocks Moving In Thursday's Pre-Market Session
June 02, 2022
Via
Benzinga
74 Biggest Movers From Yesterday
June 03, 2022
Gainers
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
June 02, 2022
Good morning, investors! It's time to start another day of trading with the biggest pre-market stock movers for Thursday!
Via
InvestorPlace
53 Stocks Moving In Thursday's Mid-Day Session
June 02, 2022
Gainers
Via
Benzinga
24 Stocks Moving in Thursday's Pre-Market Session
June 02, 2022
Gainers Immix Biopharma, Inc. (NASDAQ: IMMX) rose 42.2% to $2.63 in pre-market trading after declining around 14% on Wednesday. Immix Biopharma, last month, announced positive interim data from an...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
June 01, 2022
Gainers
Via
Benzinga
77 Biggest Movers From Yesterday
June 01, 2022
Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) shares climbed 364% to close at $9.93 on Tuesday after the company announced it has entered into a definitive merger agreement to be acquired by an affiliate...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 31, 2022
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.